Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene

References

• Wiman B. Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease. Thromb Haemost 1995; 74: 71–6
   PubMed Web of Science ®Google Scholar
• Eriksson B, Eriksson E, Gysan der E, Teger-Nilsson A-C, Thorsen S, Risberg B. Thrombosis after hip replacement. Relationship to the fibrinolytic system. Acta Orthop Scand 1989; 60: 159–63
   PubMed Web of Science ®Google Scholar
• Schulman S, Wiman B. The significance of hypo-fibrinolysis for the risk of recurrence of venous thromboembolism. Thromb Haemost 1996; 75: 607–11
   PubMed Web of Science ®Google Scholar
• Dawson S, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arteriosclerosis Thromb 1991; 11: 183–90
   PubMed Web of Science ®Google Scholar
• Dawson S J, Wiman B, Hamsten A, Green F, Humphries S, Henney A M. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993; 268: 10739–45
   PubMed Web of Science ®Google Scholar
• Erickson L A, Ginsberg M H, Loskutoff D J. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984; 74: 1465–72
   PubMed Web of Science ®Google Scholar
• Kruithof E K, Tran Thang C, Bachmann F. Studies on the release of a plasminogen activator inhibitor by human platelets. Thromb Haemost 1986; 55: 201–205
   PubMed Web of Science ®Google Scholar
• Sprengers E D, Akkerman J W, Jansen B G. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood. Thromb Haemost 1986; 55: 325–9
   PubMed Web of Science ®Google Scholar
• Kruithof E K, Nicolosa G, Bachmann F. Plasminogen activator inhibitor 1: development of a radioimmunoassay and observations on its plasma concentration during venous occlusion and after platelet aggregation. Blood. 1987; 70: 1645–53
   PubMed Web of Science ®Google Scholar
• Urdén G, Chmielewska J, Carlsson T, Wiman B. Immunological relationship between plasminogen activator inhibitors from different sources. Thromb Haemost 1987; 57: 29–34
   PubMed Web of Science ®Google Scholar
• Booth N A, Simpson A J, Croll A, Bennett B, MacGregor I R. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Br J Haematol 1988; 70: 327–33
   PubMed Web of Science ®Google Scholar
• Fay W P, Owen W G. Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C. Biochemistry 1989; 28: 5773–8
   PubMed Web of Science ®Google Scholar
• Simpson A J, Booth N A, Moore N R, Bennett B. Distribution of plasminogen activator inhibitor (PAI-1) in tissues. J Clin Pathol 1991; 44: 139–43
   PubMed Web of Science ®Google Scholar
• Lang I M, Marsh J J, Moser K M, Schleef R R. Presence of active and latent type 1 plasminogen activator inhibitor associated with porcine platelets. Blood 1992; 80: 2269–74
   PubMed Web of Science ®Google Scholar
• Booth N A, Croll A, Bennet B. The activity of plasminogen inhibitor-1 (PAI-1) of human platelet. Fibrinolysis 1990; 4(Suppl 2)138–40
   Google Scholar
• Hekman C M, Loskutoff D J. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J Biol Chem 1985; 260: 11581–7
   PubMed Web of Science ®Google Scholar
• Lindahl T L, Sigurdardottir O, Wiman B. Stability of plasminogen activator inhibitor 1 (PAI-1). Thromb Haemostas. 1989; 62: 748–51
   PubMed Web of Science ®Google Scholar
• Declerck P J, De Mol M, Alessi M C, Baudner S, Paques E, Preissner K, et al. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 1988; 263: 15454–61
   PubMed Web of Science ®Google Scholar
• Wiman B, Almquist Å, Sigurdardottir O, Lindahl T. Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma. FEBS Lett 1988; 242: 125–128
   PubMed Web of Science ®Google Scholar
• Preissner K T, Holzhüter S, Justus C, Müller-Berghaus G. Identification and partial characterization of platelet vitronectin: Evidence for complex formation with platelet-derived plasminogen activator inhibitor-1. Blood 1989; 74: 1989–1996
   PubMed Web of Science ®Google Scholar
• Braaten J V, Handt S, Jerome W G, Kirkpatrick J, Lewis J C, Hantgan R R. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus. Blood 1993; 81: 1290–9
   PubMed Web of Science ®Google Scholar
• Torr-Brown S R, Sobel B E. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets. Thromb Res 1993; 72: 413–21
   PubMed Web of Science ®Google Scholar
• Biemond B J, Levi M, Coronel R, Janse M J, ten Cate J W, Pannekoek H. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody. Circulation 1995; 91: 1175–81
   PubMed Web of Science ®Google Scholar
• Falk G, Almqvist Å, Nordenhem A, Svensson H, Wiman B. Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis 1995; 9: 170–4
   Google Scholar
• Andreotti F, Davies G J, Hackett D R, Khan M I, de Bart A C, Aber V R, et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol 1988; 62: 635–7
   PubMed Web of Science ®Google Scholar
• Eklund A G, Sigurdardottir O, öhrn M. Vitronectin and its relationship to other extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis. Am Rev Respir Dis 1992; 145: 646–650
   PubMed Web of Science ®Google Scholar
• Tijssen P, Kustak E. Highly efficient and simple methods for the preparation of peroxidase and active peroxidase-antibody conjugates for enzyme immunoassays. Analyt Biochem 1984; 136: 451–7
   PubMed Web of Science ®Google Scholar
• Konkle B A, Schick P A, Xiaoli H, Liu R J, Mazur E M. Plasminogen activator inhibitor-1 mRNA is expressed in platelets and megakaryocytes and megakaryoblastic cell line CHRF- 288. Arteriosclerosis and Thromb 1993; 13: 669–74
   PubMed Web of Science ®Google Scholar
• Ehrlich H J, Gebbink R K, Preissner K T, Keijer J, Esmon N L, Mertens K, Pannekoek H. Thrombin neutralizes plasminogen activator inhibitor 1 (PAI-1) that is complexed with vitronectin in the endothelial cell matrix. J Cell Biol 1991; 115: 1773–81
   PubMed Web of Science ®Google Scholar
• Lang I M, Schleef R R. Calcium-dependent stabilization of type I plasminogen activator inhibitor within platelet α-granules. J Biol Chem 1996; 271: 2754–61
   PubMed Web of Science ®Google Scholar